SCHEMBL2835932

SCHEMBL2835932

CCOC(=O)CCNCc1ccco1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.55
TSHR P16473 3/20 0.51
ATM Q13315 1/20 0.50
CHRM2 P08172 1/20 0.50
KDM4E B2RXH2 2/20 0.49
LMNA P02545 1/20 0.49
POLB P06746 3/20 0.47
HSD17B10 Q99714 3/20 0.47
HPGD P15428 2/20 0.47
TP53 P04637 1/20 0.47
MAPT P10636 3/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
HTT P42858 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
MAPK1 P28482 1/20 0.46
PTPN7 P35236 1/20 0.46
TDP1 Q9NUW8 2/20 0.46
EPHX2 P34913 1/20 0.46
ESR1 P03372 1/20 0.46
ALOX15 P16050 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8305118 0.87 CHRM2 (0.54) ALDH1A1TSHRATMCHRM2KDM4E
SCHEMBL2841443 0.85 TSHR (0.53) ALDH1A1TSHRATMKDM4ELMNA
SCHEMBL64663 0.80 ALDH1A1 (0.51) ALDH1A1TSHRKDM4EPOLBHSD17B10
SCHEMBL10005850 0.80 CHRM2 (0.57) ALDH1A1TSHRATMCHRM2KDM4E
SCHEMBL9372019 0.79 TSHR (0.59) ALDH1A1TSHRATMCHRM2KDM4E
SCHEMBL11164243 0.78 ALDH1A1 (0.60) ALDH1A1TSHRKDM4EPOLBHSD17B10
SCHEMBL1645027 0.77 ALDH1A1 (0.54) ALDH1A1TSHRKDM4ELMNAPOLB
SCHEMBL6641439 0.77 CYP4F2 (0.55) ALDH1A1TSHRPOLBHSD17B10HPGD
SCHEMBL549268 0.76 LTA4H (0.60) ALDH1A1ATMPOLBMAPTSMN1; SMN2
SCHEMBL9403764 0.76 HSD17B10 (0.61) ALDH1A1TSHRKDM4ELMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8217031-B2 Heteroaryl derivatives NIPPON SHINYAKU CO., LTD. (JP) 2012-07-10 US disclosed
CN-101646678-B heteroaryl derivatives NIPPON SHINYAKU CO LTD 2012-05-30 CN disclosed
US-20100048537-A1 HETEROARYL DERIVATIVES NIPPON SHINYAKU CO., LTD. (JP) 2010-02-25 US disclosed
EP-2141168-A1 HETEROARYL DERIVATIVES Nippon Shinyaku Co., Ltd. (JP) 2010-01-06 EP disclosed
WO-1996036595-A1 3,4-DISUBSTITUTED-PHENYLSULPHONAMIDES AND THEIR THERAPEUTIC USE CHIROSCIENCE LIMITED (GB) 1996-11-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048537-A1 HETEROARYL DERIVATIVES OPRD1, OPRM1, OPRK1 ALDH1A1 66/4885TSHR 1940/4885ATM 2583/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.